Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate vs Lidocaine with Diclofenac for Renal Colic
NCT03199924Phase 2Completed
- Sponsor
- Université de Monastir
- Start
- Jul 2016
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of magnesium sulfate and Lidocaine Hydrochloride Injection, without epinephrine in Renal colic (3 arms), sponsored by Université de Monastir. Primary endpoints: Treatment success evaluated at 30 minutes after drug administration and Pain resolution time at 90 months. Started Jul 2016; status: completed.
02
Drugs
magnesium sulfateLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
Renal colic
Beyond the preview
Go deeper on NCT03199924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03199924.